Investigating the diagnostic performance of HOTTIP, PVT1, and UCA1 long noncoding RNAs as a predictive panel for the screening of colorectal cancer patients with lymph node metastasis. Issue 9 (16th April 2019)

• Record Type: Journal Article
• Authors: Gharib, Ehsan; Anaraki, Fakhrosadat; Baghdar, Kaveh; Ghavidel, Pegah; Sadeghi, Hossein; Nasrabadi, Parinaz Nasri; Peyravian, Noshad; Aghdaei, Hamid Asadzadeh; Zali, Mohammad Reza; Mojarad, Ehsan Nazemalhosseini
• Is Part Of: Journal of cellular biochemistry. Volume 120:Issue 9(2019)
• Page Start: 14780
• Page End: 14790
• Publication Date: 2019-04-16
• Subjects: biomarker -- colorectal cancer -- HOTTIP -- lymph node metastasis -- PVT1 -- UCA1; Cytochemistry -- Periodicals; 572
• DOI: 10.1002/jcb.28739
• Languages: English
• ISSNs: 0730-2312

Abstract

Abstract: Like other noncoding RNAs (ncRNAs), dysregulation of long ncRNAs (lncRNAs) has been associated with various clinicopathological features of colorectal cancer (CRC) patients such as lymph node metastasis (LNM). Recently, three aberrant expressed oncogenic lncRNA (onco‐lncRNAs), including HOXA transcript at the distal tip (HOTTIP), plasmacytoma variant translocation 1 (PVT1), and urothelial carcinoma associated 1 (UCA1) have been reported in LNM. Herein, we compared the diagnostic performance of these lncRNAs as individual biomarkers and as a discriminating panel between LNM CRC patients, nonmetastatic lymph nodes (NLN) and normal healthy subjects. The lncRNAs expression level was measured by quantitative real‐time PCR and analyzed by the Mann‐Whitney U test. The receiver operating characteristic (ROC) curve analysis was applied to evaluate the diagnostic power. The Kaplan‐Meier survival analysis was performed to outline the overall survival (OS) of CRC patients with an abnormal level of lncRNAs. The area under the ROC curve (AUC) of the overexpressed HOTTIP (0.7817; 95% CI, 0.6809‐0.8824), PVT1 (0.8559; 95% CI, 0.7737‐0.9382), and UCA1 (0.8135; 95% CI, 0.722‐0.9051) introduced them as individual CRC biomarkers. As a predictive panel, the AUC values of the HOTTIP, PVT1, and UCA1 for training set were 0.9256 (95% CI, 0.8634‐0.9879; all CRCs), 0.8708 (95% CI, 0.7709‐0.9378; NLN) and 0.9804 (95% CI, 0.9585‐0.9998; LNM), and for validation set were 0.9286 (95% CI, 0.8752‐0.9820; all CRCs), 0.8911 (95% CI, 0.8238‐0.9585; NLN), and 0.9833 (95% CI, 0.9642‐1.002; LNM), respectively. Also, HOTTIP/PVT1/UCA1 panel dysregulation had a marked correlation with patient's OS in training set (logrank test P = 0.0121; hazard ratio [HR], 0.1225; 95% confidence interval [CI], 0.02376‐0.6312), and in validation set (logrank test P < 0.0001, HR, 0.2003; 95% CI, 0.08942‐0.4486). These data showed that the combination of HOTTIP, PVT1, and UCA1 as a predictive panel, has a better diagnostic performance than each of these lncRNAs individually, and could be used for the screening of patients with advanced CRC.